Recent Nationwide Trends in Discharge Statin Treatment of Hospitalized Patients With Stroke | Zendy

Bruce Ovbiagele | Zendy; Lee H. Schwamm | Zendy; Eric E. Smith | Zendy; Adrian F. Hernandez | Zendy; DaiWai M. Olson | Zendy; Wenqin Pan | Zendy; Gregg C. Fonarow | Zendy; Jeffrey L. Saver | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Recent Nationwide Trends in Discharge Statin Treatment of Hospitalized Patients With Stroke

Author(s) -

Bruce Ovbiagele,

Lee H. Schwamm,

Eric E. Smith,

Adrian F. Hernandez,

DaiWai M. Olson,

Wenqin Pan,

Gregg C. Fonarow,

Jeffrey L. Saver

Publication year - 2010

Publication title -

stroke

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.397

H-Index - 319

eISSN - 1524-4628

pISSN - 0039-2499

DOI - 10.1161/strokeaha.109.573618

Subject(s) - medicine , stroke (engine) , statin , medical prescription , emergency medicine , ischemic stroke , hospital discharge , clinical trial , ischemia , mechanical engineering , engineering , pharmacology

The Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial showed statins reduce vascular risk among patients with atherosclerotic stroke or transient ischemic attack. In this study, we assessed recent nationwide trends in discharge statin treatment after acute stroke and the influence of SPARCL on clinical practice.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research